Doxorubicin (LIDDS)

N/A

Report date: 2026/01/26 13:50:14

Base Information

Drug NameDoxorubicin (LIDDS)
Drug Alias NameNZ-DOX
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics
Mechanisms of ActionVirus DNA polymerase inhibitorsTopoisomerase II inhibitorsDNA intercalators
TargetsVirus DNA polymeraseDNATopoisomerase II
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLidds Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLidds Ab
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A